MCK Q4 2021 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q4 2021 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$59.1B+1.0% YoY

Gross Profit

$3.2B5.3% margin

Operating Income

$1.1B1.9% margin

Net Income

$666M1.1% margin

EPS (Diluted)

$4.15

QoQ Revenue Growth

-5.5%

Cash Flow

Operating Cash Flow

$3.4B

Free Cash Flow

$3.2B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$65.0B

Total Liabilities

$63.6B

Stockholders' Equity

-$21M

Cash & Equivalents

$6.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59.1B	$58.5B	+1.0%
Gross Profit	$3.2B	$3.1B	+1.8%
Operating Income	$1.1B	$1.2B	-8.3%
Net Income	$666M	$1.0B	-34.8%

Revenue Segments

U.S. Pharmaceutical Segment

$46.6B69%

International Segment

$17.2B25%

Medical-Surgical Solutions Segment

$2.7B4%

Prescription Technology Solutions

$1.4B2%